UCSF QBI and Icahn School of Medicine at Mount Sinai Scientists Report New Preclinical Data Published in Science on Potential Best-in-Class COVID-19 Anti-Viral Treatment: Plitidepsin

Additionally, they found plitidepsin to be ~100 times more potent than remdesivir in human epithelial cells.